Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome
twins
1 other identifier
interventional
286
1 country
1
Brief Summary
In the present study, we hypothesized that primary mode nIPPV initiated shortly after birth would decrease the incidence of intubation or death in twin infants when compared to nCPAP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 8, 2013
CompletedFirst Posted
Study publicly available on registry
August 20, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2017
CompletedDecember 7, 2017
August 1, 2013
5.1 years
August 8, 2013
December 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of intubation
48h
Secondary Outcomes (1)
incidence of BPD
1 month
Other Outcomes (1)
death
3 months
Study Arms (2)
nIPPV
EXPERIMENTALthe infants in the arm were supported by Nasal Intermittent Positive-Pressure Ventilation(nIPPV)
nCPAP
ACTIVE COMPARATORthe infants in the arm were supported by Nasal Continuous Positive Airway Pressure(nCPAP)
Interventions
Eligibility Criteria
You may qualify if:
- Twins
- Clinical diagnosis of mild-moderate respiratory distress syndrome
- requiring a fraction of inspired oxigen (FiO2 ) \<0.40 to keep oxygen saturation of 90%-95%
- a chest X-ray suggestive of early stage hyaline membrane disease, (i.e. mild microgranulia and air bronchogram)
You may not qualify if:
- pneumothorax
- pneumomediastinum
- surgical diseases
- cardiac diseases
- intraventricular hemorrage
- major congenital defects
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University
Chongqing, Chongqing Municipality, 400042, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Long Chen, MD
Department of Pediatrics, Daping Hospital, Research Institute of Surgery, Third Military Medical University,
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof;MD
Study Record Dates
First Submitted
August 8, 2013
First Posted
August 20, 2013
Study Start
July 1, 2012
Primary Completion
July 30, 2017
Study Completion
July 30, 2017
Last Updated
December 7, 2017
Record last verified: 2013-08